Takeda Pharmaceutical Company Limited Share Price & Technical Analysis

TAK · $15.87 (-2.34%)

Healthcare / Drug Manufacturers - Specialty & Generic

AI Score 36 · Bearish

$15.87

-2.34%

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takec

Price chart

Seasonality

May has 1 positive and 4 negative years (last 5 years shown)

-2% return in May, -1% avg return in past 3 year May month.

7% return in 2026, 3% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
2610%9%0%-10%-2%7%
252%9%2%2%-1%3%-11%6%-3%-8%7%8%16%
244%-1%-4%-5%2%-4%7%10%-4%-3%-3%-3%-5%
231%-2%8%1%-5%-1%-2%3%0%-11%4%2%-1%
226%6%-6%1%-1%-3%5%-3%-5%2%11%5%17%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 36/100

Bearish · Downtrend · Weak

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba Fiber, Recombinate, Hemofil, Immunate, Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-licensing agreements with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaborations with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Institute, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, and Teva Pharmaceutical Industries; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei, Zedira/Dr. Falk Pharma, Exelixi GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, KM Biologics, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics. The company was founded in 1781 and is headquartered in Tokyo, Japan.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$52.24B

P/E ratio

71.89

52W high

$18.90

52W low

$12.99

Volume

31,06,936

Beta

0.10

Related stocks in Healthcare

Frequently asked questions

What is Takeda Pharmaceutical Company Limited share price today?
Takeda Pharmaceutical Company Limited (TAK) last traded around $15.87 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does TAK have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for TAK. Download the app for real-time alerts.
How can I analyze Takeda Pharmaceutical Company Limited stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro